002603.SZ
以岭药业
SZSE · Healthcare · C 制造业 · CN
CNY 15.84
−3.71%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
11.5x
Market Cap
CNY 26.46B
MomentumView details →
1D Return
−3.71%
YTD Return
−7.03%
RSI (14)
43.6
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
11.5x
Market Cap
CNY 26.46B
RSI (14)
43.6
MomentumView details →
1D Return
−3.71%
YTD Return
−7.03%
Similar companies
Latest newsMore news →
China's 2026 National Essential Medicines List took effect on September 1, adding 116 new drugs including four domestic Class 1 innovative drugs and Novo Nordisk's semaglutide.4d agoYiling Pharmaceutical announced its first-half 2026 results with revenue of 4.075 billion yuan, net profit of 757 million yuan, and no dividend distribution.8d ago